Emerging2 activitiesPharmaceutical intelligence

Zantac

Pharmaceutical · claims concerning NDMA contamination and alleged cancer risk from ranitidine pro…

DEFENDANT

Pharmaceutical

MDL / TRACK

See litigation status

JUDGE

Various

PLAINTIFFS

Emerging

BELLWETHER / TRIAL

TBD

SETTLEMENT STATUS

Pending

Case overview Litigation status Geographic exposure Key defendants Timeline Statute of limitations Live activity

Live intelligence

AI litigation brief

Zantac remains emerging with 2 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Zantac: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Zantac: court filing watch. openFDA regulatory on Mar 10: Zantac: FDA regulatory alert.

Trajectory

The feed is being driven by court-side movement, so docket scheduling and case-management orders should lead the next editorial update for Zantac.

Editorial intelligence

Editorial coverage should stay tied to source-backed developments and avoid placeholder status copy for Zantac.

Generated Mar 10, 2026, 11:39 AM

PACER

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 3 minutes

Last fetch Mar 10, 2026, 11:36 AM

Next fetch Mar 10, 2026, 12:36 PM

Google News

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 4 minutes

Last fetch Mar 10, 2026, 11:35 AM

Next fetch Mar 10, 2026, 12:35 PM

FAERS

Live

Target freshness: within 15 minutes of upstream fetch.

Lag 11 minutes

Last fetch Mar 10, 2026, 11:28 AM

Next fetch Mar 10, 2026, 12:28 PM

PubMed

Live

Target freshness: within 30 minutes of upstream fetch.

Lag 21 minutes

Last fetch Mar 10, 2026, 11:18 AM

Next fetch Mar 10, 2026, 12:18 PM

2 activities detected

⚖️CourtPACER

Detected Mar 10, 2026, 11:34 AM

Zantac: court filing watch

Federal Courts watchlist initialized for Zantac. Captions, docket numbers, and venue context are validated before promotion.

AI Litigation Note

PACER court filing on Mar 10 for Zantac. Zantac: court filing watch — Federal Courts watchlist initialized for Zantac. Captions, docket numbers, and venue context are validated before promotion. Monitor docket for scheduling orders, CMOs, and bellwether selections.

Generated Mar 10, 2026, 11:33 AM

Confidence 88%Published Mar 10, 2026, 11:32 AM

View Original Source →

📜RegulatoryFDA

Detected Mar 10, 2026, 11:15 AM

Zantac: FDA regulatory alert

openFDA monitoring is active for Zantac. FDA safety alerts, recalls, and enforcement reports are tracked via direct API connection.

AI Litigation Note

openFDA regulatory on Mar 10 for Zantac. Regulatory developments can change intake posture and motion practice quickly.

Generated Mar 10, 2026, 11:14 AM

Confidence 88%Published Mar 10, 2026, 11:13 AM

LexGenius Ranking

68Active Watch

Signal volume is building across tracked sources

Evidence16 / 20

Momentum12 / 20

Exposure14 / 20

Regulatory14 / 20

Legal12 / 20

Monitoring

60 min

refresh interval

Last: Mar 10, 2026, 11:27 AM

Next: Mar 10, 2026, 12:27 PM

Signal feed

activities detected

Google NewsPACERFAERSPubMed

AI Brief

Zantac remains emerging with 2 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Zantac: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Zantac: court filing watch. openFDA regulatory on Mar 10: Zantac: FDA regulatory alert.

Generated Mar 10, 2026, 11:39 AM

← Previous

California Women's Prisons

Monitors litigation, oversight, and policy reporting involving abuse claims in California women’s prisons.

End of catalog